Rare Allergy's hidden toll: study aims to quantify suffering

NCT ID NCT07391917

First seen Feb 06, 2026 · Last updated Jun 22, 2026 · Updated 18 times

Summary

Human seminal plasma allergy is a rare condition causing pain and inflammation after unprotected sex, but its impact on quality of life is poorly understood. This study will enroll 20 women treated at Angers University Hospital to compare standard quality-of-life questionnaires and a simple rating question. The goal is to describe how this allergy affects physical, mental, and sexual health, and to determine if a disease-specific questionnaire is needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC REACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sandra MERZEAU

    Angers, 49933, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could show how much this rare allergy affects daily life and sexual health, and support the creation of a dedicated quality-of-life questionnaire.

What could go wrong

This is a small, early-stage observational study with only 20 participants, so results may not apply to everyone. It does not test a treatment, so no direct health benefit is expected.

Conditions

The condition(s) this trial relates to.

allergic disease hypersensitivity reaction disease Sexuality

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.